The Food and Drugs Authority (FDA) has revoked the Good Manufacturing Practices (GMP) certification of Aveo Pharmaceuticals, ...
Days afta di BBC Africa eye don publish di latest exposé about one pharmaceutical company for India wey don dey produce ...
The FDA has approved label changes for once-monthly Sublocade, helping to reduce possible barriers to treatment initiation ...
2d
WRIC Richmond on MSNFDA approves first opioid-free painkiller in over two decadesThe U.S. Food and Drug Administration (FDA) has approved Journavx, the first opioid-free prescription drug for moderate to ...
Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...
Through the Arkansas Opioid Recovery Partnership, we have funded innovative programs aimed to slow the relentless increase in ...
5d
GlobalData on MSNGLP-1RAs and opioid use disorder: a new frontier in addiction treatmentWhile medications such as methadone, buprenorphine, and naltrexone are FDA-approved for treating opioid use disorder, they ...
SB161 would require that non-opioid pain treatments that have FDA approval be included on this preferred drug list with coverage terms that are no more restrictive than those given to opioid pain ...
A raid was conducted on Aveo Pharmaceuticals, accused of illegally manufacturing and exporting addictive opioids to West ...
Indivior said the U.S. Food and Drug Administration approved label changes for its opioid-dependence treatment Sublocade, including a rapid initiation protocol and alternative injection sites.
The case emerged following an investigative report by BBC, which uncovered the sale of Aveo-branded combination medicines in ...
Advancements have been made in the pain management field that have successfully found FDA approved alternatives to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results